Global pharma firms face 'foreign policy' tests
You must be signed in to read this analysis
In this article
- Big challenges, emerging markets
- Death penalty drugs
- Individual CEO Liability
- Buy-ups of generic firms
What is this?
This article is from the Oxford Analytica Daily Brief, which analyses geopolitical, economic, social, business and industrial developments on a global and regional basis, providing clients with timely, authoritative analysis every business day of the year. Find out more about the Oxford Analytica Daily Brief, or request a trial.